
T&L Co., Ltd. (340570.KQ)
ValueMarkers Composite Index
81% below intrinsic value ($180)
T&L Co., Ltd. (340570.KQ) — VMCI valuation read
Across 120 indicators, T&L Co., Ltd. (340570.KQ) lands at VMCI 73/100. The Healthcare sector median is 50, so the 23-point above-median read is the active comparison. Pillar weighting on the score: Value 35%, Quality 30%, Integrity 15%, Growth 12%, Risk 8%.
No material Form 4 disclosures landed on 340570.KQ in the past 30 days. Quiet insider tape removes one signal source; the active reads stay with the trailing-twelve-month financials and the next 10-Q.
**Investor frame.** On Value, 340570.KQ trades at 21.0x earnings, 17% above the Healthcare median of 18.0x; the EV/EBITDA delta of -2.0x reinforces that single line. On Quality, ROIC of 9.0% trails the Healthcare median (10.0%) by 1.0pp. On Risk, net debt to EBITDA of -1.3x leaves covenant headroom for 340570.KQ on the trailing balance sheet.
340570.KQ fell 2.3% over the trailing 7 days, with a -1.1% read on a 30-day basis.
Related Stocks in Healthcare
Top peers ranked by VM Score. Compare valuation, quality, and risk metrics across the sector.
- CSWYF - China Shineway Pharmaceutical Group Limited
- CSWYF - China Shineway Pharmaceutical Group Limited
- 7634.T - Hoshi Iryo-Sanki Co., Ltd.
- KROS - Keros Therapeutics, Inc.
- KROS - Keros Therapeutics, Inc.
- TSPC.JK - PT Tempo Scan Pacific Tbk
- OTSKY - Otsuka Holdings Co., Ltd.
- 4931.T - Shinnihonseiyaku Co., Ltd.